|
Sample ID
|
Gender
|
Race
|
Tumor status
|
Vital status
|
Grade
|
Residual
|
Metastasis stage
|
Pathologic tumor stage
|
|---|
|
TCGA-BC-A10Q-01A
|
Female
|
White
|
With Tumor
|
Dead
|
NA
|
R1
|
MX
|
NA
|
|
TCGA-CC-5260-01A
|
Female
|
Asian
|
Tumor Free
|
Alive
|
G1
|
RX
|
M0
|
Stage IIIC
|
|
TCGA-G3-A25T-01A
|
Female
|
White
|
Tumor Free
|
Alive
|
G2
|
R0
|
M0
|
Stage IIIA
|
|
TCGA-CC-A3M9-01A
|
Male
|
Asian
|
Tumor Free
|
Alive
|
G3
|
R0
|
M0
|
Stage IIIA
|
|
TCGA-FV-A3I0-01A
|
Female
|
White
|
Tumor Free
|
Alive
|
G2
|
R0
|
M0
|
Stage II
|
|
TCGA-DD-A3A6-01A
|
Female
|
White
|
Tumor Free
|
Dead
|
G2
|
R0
|
M0
|
Stage II
|
|
TCGA-CC-A7IJ-01A
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
|
TCGA-ED-A82E-01A
|
Female
|
Asian
|
Tumor Free
|
Alive
|
G2
|
R0
|
M0
|
Stage IIIA
|
|
Fisher test (P value)
|
0.01
|
0.69
|
0.68
|
0.76
|
0.16
|
0.45
|
1
|
0.16
|
- Two-tailed Fisher's exact test was used for associating clinical features to the tumors.
